Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Asset Utilization Ratio (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Asset Utilization Ratio data on record, last reported at 0.02 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 46.48% year-over-year to 0.02; the TTM value through Sep 2025 reached 0.02, down 46.48%, while the annual FY2024 figure was 0.04, 309.71% up from the prior year.
  • Asset Utilization Ratio reached 0.02 in Q3 2025 per BTAI's latest filing, down from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.05 in Q4 2024 and bottomed at 0.02 in Q1 2023.
  • Average Asset Utilization Ratio over 4 years is 0.02, with a median of 0.02 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 330.32% in 2024, then plummeted 46.48% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.02 in 2022, then skyrocketed by 179.06% to 0.02 in 2023, then skyrocketed by 227.82% to 0.05 in 2024, then crashed by 58.99% to 0.02 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.02 in Q3 2025, 0.03 in Q2 2025, and 0.05 in Q1 2025.